Height-based Formula for Predicting the Insertion Depth of Left-sided Double and the Role of Fiberoptic Bronchoscopy

Sponsor
King Saud University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04449770
Collaborator
(none)
70
1
22
3.2

Study Details

Study Description

Brief Summary

The use of height based formula to predict insertion depth of left-sided double lumen tube in thoracic surgery is now well established. The investigators have developed a formula to be used and published recently. The investigators verified the formula with the use of FOB. This observational study we are going to use with FOB checking if needed.

Condition or Disease Intervention/Treatment Phase
  • Device: double lumen tube

Detailed Description

The use of a height-based formula to predict the insertion depth of left-sided double-lumen tubes in thoracic surgery is now well established. The investigators have developed a formula to be used and published recently. The investigators verified the formula with the use of FOB. This observational study will use FOB checking if needed.

Our hypothesis is that DLT can insert without the use of FOB in most of the cases. That doesn't mean FOB is less required.

Study Design

Study Type:
Observational
Anticipated Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Study on the Use of an Established Novel Height-based Formula for Predicting the Insertion Depth of Left-sided Double and the Role of Fiberoptic Bronchoscopy
Anticipated Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Jun 1, 2022

Outcome Measures

Primary Outcome Measures

  1. correct position of DLT with proper lung deflation without use of FOB [during surgical time]

    proper lung deflation, surgeon satisfaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients whose procedure required placement of an LDLT
Exclusion Criteria:
  • patients with intraluminal bronchial lesions and patients with a difficult airway.

Contacts and Locations

Locations

Site City State Country Postal Code
1 King Saud University Riyadh Saudi Arabia 11462

Sponsors and Collaborators

  • King Saud University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
A.Eldawlatly, professor, King Saud University
ClinicalTrials.gov Identifier:
NCT04449770
Other Study ID Numbers:
  • E-18-3064/IRB 06.05.2018
First Posted:
Jun 29, 2020
Last Update Posted:
Jul 10, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by A.Eldawlatly, professor, King Saud University

Study Results

No Results Posted as of Jul 10, 2020